TSG101 plays an indispensable role in the processing of these viral late proteins, explaining why increasing TGS101 is broadly observable during EBV lytic reactivation no matter how it is induced; e.g., transfection of Zta and Rta in NPC cells or anti-IgG treatment in BL cells. The gene discussed is TSG101; the disease is nasopharyngeal carcinoma.